219 related articles for article (PubMed ID: 33053434)
1. Evidence of early vasogenic edema following minor head impact that can be reduced with a vasopressin V1a receptor antagonist.
Kulkarni P; Bhosle MR; Lu SF; Simon NS; Iriah S; Brownstein MJ; Ferris CF
Brain Res Bull; 2020 Dec; 165():218-227. PubMed ID: 33053434
[TBL] [Abstract][Full Text] [Related]
2. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging.
Barzó P; Marmarou A; Fatouros P; Hayasaki K; Corwin F
J Neurosurg; 1997 Dec; 87(6):900-7. PubMed ID: 9384402
[TBL] [Abstract][Full Text] [Related]
3. Treating head injury using a novel vasopressin 1a receptor antagonist.
Morrison TR; Kulkarni P; Cai X; Iriah S; Aggarwal D; Lu SF; Simon NG; Madularu D; Ferris CF
Neurosci Lett; 2020 Jan; 714():134565. PubMed ID: 31639422
[TBL] [Abstract][Full Text] [Related]
4. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
Krieg SM; Sonanini S; Plesnila N; Trabold R
J Neurotrauma; 2015 Feb; 32(4):221-7. PubMed ID: 25111427
[TBL] [Abstract][Full Text] [Related]
5. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
Marmarou CR; Liang X; Abidi NH; Parveen S; Taya K; Henderson SC; Young HF; Filippidis AS; Baumgarten CM
Brain Res; 2014 Sep; 1581():89-102. PubMed ID: 24933327
[TBL] [Abstract][Full Text] [Related]
6. The effects of a butanediol treatment on acute focal cerebral ischemia assessed by quantitative diffusion and T2 MR imaging.
Loubinoux I; Volk A; Borredon J; Guirimand S; Tiffon B; Seylaz J; Méric P
Magn Reson Imaging; 1997; 15(9):1045-55. PubMed ID: 9364951
[TBL] [Abstract][Full Text] [Related]
7. Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
Neurocrit Care; 2016 Apr; 24(2):273-82. PubMed ID: 26732270
[TBL] [Abstract][Full Text] [Related]
8. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
Kleindienst A; Dunbar JG; Glisson R; Marmarou A
Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
[TBL] [Abstract][Full Text] [Related]
9. Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
Taya K; Gulsen S; Okuno K; Prieto R; Marmarou CR; Marmarou A
Acta Neurochir Suppl; 2008; 102():425-9. PubMed ID: 19388360
[TBL] [Abstract][Full Text] [Related]
10. Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.
Filippidis AS; Liang X; Wang W; Parveen S; Baumgarten CM; Marmarou CR
J Neurotrauma; 2014 Jul; 31(14):1258-67. PubMed ID: 24635833
[TBL] [Abstract][Full Text] [Related]
11. Biphasic pathophysiological response of vasogenic and cellular edema in traumatic brain swelling.
Barzó P; Marmarou A; Fatouros P; Hayasaki K; Corwin F
Acta Neurochir Suppl; 1997; 70():119-22. PubMed ID: 9416297
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of vasopressin v1a receptors after traumatic brain injury.
Szmydynger-Chodobska J; Chung I; Koźniewska E; Tran B; Harrington FJ; Duncan JA; Chodobski A
J Neurotrauma; 2004 Aug; 21(8):1090-102. PubMed ID: 15319008
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat.
Kleindienst A; Fazzina G; Dunbar JG; Glisson R; Marmarou A
Acta Neurochir Suppl; 2006; 96():303-6. PubMed ID: 16671476
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of rabbit brain edema in focal lesion and perilesion area after traumatic brain injury: a MRI study.
Wei XE; Zhang YZ; Li YH; Li MH; Li WB
J Neurotrauma; 2012 Sep; 29(14):2413-20. PubMed ID: 21675826
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging of edema following traumatic brain injury in rats: effects of secondary hypoxia.
Van Putten HP; Bouwhuis MG; Muizelaar JP; Lyeth BG; Berman RF
J Neurotrauma; 2005 Aug; 22(8):857-72. PubMed ID: 16083353
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study.
Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H
Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630
[TBL] [Abstract][Full Text] [Related]
17. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
Kagawa M; Nagao S; Bemana I
J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177
[TBL] [Abstract][Full Text] [Related]
18. Dynamic features of brain edema in rat models of traumatic brain injury.
Ren H; Lu H
Neuroreport; 2019 Jun; 30(9):605-611. PubMed ID: 30969247
[TBL] [Abstract][Full Text] [Related]
19. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
Schulz J; Plesnila N; Eriskat J; Stoffel M; Pruneau D; Baethmann A
Acta Neurochir Suppl; 2000; 76():137-9. PubMed ID: 11449993
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic Edema Associated with Hemorrhage Predicts Poor Outcome after Traumatic Brain Injury.
Turtzo LC; Luby M; Jikaria N; Griffin AD; Greenman D; Bokkers RPH; Parikh G; Peterkin N; Whiting M; Latour LL
J Neurotrauma; 2021 Nov; 38(22):3107-3118. PubMed ID: 34541886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
